These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6831822)

  • 1. An intra-arterial profile of methyldopa.
    Gould BA; Hornung RS; Kieso HA; Cashman PM; Raftery EB
    Clin Pharmacol Ther; 1983 Apr; 33(4):438-44. PubMed ID: 6831822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prazosin alone and combined with a beta-adrenoreceptor blocker in treatment of hypertension.
    Gould BA; Hornung RS; Kieso HA; Cashman PM; Raftery EB
    J Cardiovasc Pharmacol; 1983; 5(4):678-84. PubMed ID: 6193367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of alpha-methyldopa in single and divided doses on the circadian rhythm of arterial pressure in hypertensive patients].
    Carpentiere G; Castello F; Marino S
    Clin Ter; 1984 Mar; 108(6):497-502. PubMed ID: 6233068
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect on intra-arterial blood pressure of slow release metoprolol combined with placebo or chlorthalidone.
    Kieso HA; Gould BA; Mann S; Hornung RS; Altman DG; Raftery EB
    Br Med J (Clin Res Ed); 1983 Sep; 287(6394):717-20. PubMed ID: 6412795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa.
    Baldwa VS; Gupta BS; Chittora MD
    Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic changes in long-term -methyldopa therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1972 Sep; 192(3):221-6. PubMed ID: 5055268
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of antihypertensive therapy on cardiovascular response to exercise.
    Lee WR; Fox LM; Slotkoff LM
    Am J Cardiol; 1979 Aug; 44(2):325-8. PubMed ID: 463771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of anti-hypertensive drugs to control blood pressure rise with isometric exercise in hypertension.
    O'Hare JA; Murnaghan DJ
    Postgrad Med J; 1981 Sep; 57(671):552-5. PubMed ID: 6120507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of alpha- and beta-adrenergic receptor blockers on the pressure responses to isometric exercise in hypertensive patients.
    Reuben SR; Gale EV; Blake P
    Br J Clin Pharmacol; 1979 Oct; 8(4):365-8. PubMed ID: 41550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyldopa and neural control of circulation in essential hypertension.
    Mancia G; Ferrari A; Gregorini L; Bianchini C; Terzoli L; Leonetti G; Zanchetti A
    Am J Cardiol; 1980 Jun; 45(6):1237-43. PubMed ID: 6990740
    [No Abstract]   [Full Text] [Related]  

  • 13. Intra-arterial monitoring of the antihypertensive effects of once-daily amlodipine.
    Broadhurst P; Heber ME; Brigden G; al-Khawaja I; Raftery EB
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S9-12. PubMed ID: 1293307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyldopa and propranolol or practolol in moderate hypertension.
    Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT
    Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypertension with propranolol.
    Prichard BN; Gillam PM
    Br Med J; 1969 Jan; 1(5635):7-16. PubMed ID: 5761914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise.
    Magnani B; Ambrosioni E; Costa FV; Malini PL; Magelli C
    Int J Clin Pharmacol Ther Toxicol; 1981 Oct; 19(10):440-4. PubMed ID: 7287240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB
    Acta Med Scand Suppl; 1984; 681():117-23. PubMed ID: 6587750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Balasubramanian V; Raftery EB
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():113-21. PubMed ID: 6956472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ambulatory trial of guanfacine.
    Mann S; Millar Craig MW; Melville DI; Cashman PM; Raftery EB
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):103S-107S. PubMed ID: 6994762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine tablets for hypertension: a study using continuous ambulatory intra-arterial recording.
    Hornung RS; Gould BA; Jones RI; Sonecha T; Raftery EB
    Postgrad Med J; 1983; 59 Suppl 2():95-7. PubMed ID: 6889222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.